Rigel Pharmaceuticals, Inc. (RIGL)
49.42
+1.92
(+4.04%)
USD |
NASDAQ |
Sep 02, 16:00
49.46
+0.04
(+0.08%)
After-Hours: 20:00
Rigel Pharmaceuticals Cash from Investing (Quarterly) : 17.45M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.45M |
| March 31, 2026 | -7.975M |
| December 31, 2025 | -25.36M |
| September 30, 2025 | -33.18M |
| June 30, 2025 | -23.28M |
| March 31, 2025 | -10.55M |
| December 31, 2024 | -10.91M |
| September 30, 2024 | 3.802M |
| June 30, 2024 | 10.93M |
| March 31, 2024 | 0.313M |
| December 31, 2023 | -6.874M |
| September 30, 2023 | -1.17M |
| June 30, 2023 | 2.97M |
| March 31, 2023 | 0.777M |
| December 31, 2022 | 18.60M |
| September 30, 2022 | 10.46M |
| June 30, 2022 | 21.10M |
| March 31, 2022 | 22.63M |
| December 31, 2021 | 6.488M |
| September 30, 2021 | -44.40M |
| June 30, 2021 | -49.66M |
| March 31, 2021 | 7.532M |
| December 31, 2020 | 8.711M |
| September 30, 2020 | 19.53M |
| June 30, 2020 | -5.234M |
| Date | Value |
|---|---|
| March 31, 2020 | 24.46M |
| December 31, 2019 | -7.617M |
| September 30, 2019 | -0.294M |
| June 30, 2019 | -14.67M |
| March 31, 2019 | -1.073M |
| December 31, 2018 | 2.093M |
| September 30, 2018 | 15.86M |
| June 30, 2018 | -16.20M |
| March 31, 2018 | 23.22M |
| December 31, 2017 | -35.24M |
| September 30, 2017 | 7.561M |
| June 30, 2017 | 8.356M |
| March 31, 2017 | -0.15M |
| December 31, 2016 | 2.111M |
| September 30, 2016 | 10.39M |
| June 30, 2016 | 19.15M |
| March 31, 2016 | -6.771M |
| December 31, 2015 | 12.75M |
| September 30, 2015 | 30.65M |
| June 30, 2015 | -8.294M |
| March 31, 2015 | 9.511M |
| December 31, 2014 | 16.96M |
| September 30, 2014 | 7.258M |
| June 30, 2014 | 28.26M |
| March 31, 2014 | 10.46M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| Cytokinetics, Inc. | -507.00M |
| Perspective Therapeutics, Inc. | 15.02M |
| Capricor Therapeutics, Inc. | -48.76M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 30.65M |
| Cash from Financing (Quarterly) | -11.70M |
| Free Cash Flow | 9.042M |
| Free Cash Flow Per Share (Quarterly) | -2.028 |
| Free Cash Flow to Equity (Quarterly) | -33.92M |
| Free Cash Flow to Firm (Quarterly) | -39.28M |
| Free Cash Flow Yield | 0.94% |